Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A spill of new data Wednesday sent oil futures slipping and sliding in opposite directions. So is Big Oil’s tank is half-full or half-empty?
According to the Financial Times, Apple is ramping up its Apple News division. But can it fix its irritating AI hallucinations?
Alico, a major supplier to Tropicana, announced Monday that it is sunsetting its citrus business in the Sunshine State.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Despite China’s overall economy coming down with a bad cold last year, its EV players are upstaging the world’s most valuable auto company.
In a 2023 Gallup survey, 62% of American adults under 35 said they drink alcohol, down from 72% twenty years earlier.
The odds of an increase in regulation of the massive, and growing, sports-betting industry may be shifting.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
There were plenty of business losers in 2024, but only one for whom the sky was literally falling. In short: Boeing had a bad year.
Luxury brands were riding the subway instead of lounging in limos this year, though a couple of brands were able to buck the trend.
This year Big Tech got into the energy game in a big way, and if it wants to chase AI it’ll need even more energy in years to come.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.